Medicare Enrolled
Dr. Shahid Riaz, MD
Neurology · Davenport, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Riaz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Riaz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Riaz
Dr. Shahid Riaz is a neurology specialist in Davenport, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Riaz performed 809 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Riaz received a total of $15,300 from 74 pharmaceutical and/or device companies across 719 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Riaz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 36% volume in FL
$15,300 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗809
Medicare services
Top 36% in FL for neurology
Not available
Unique patients (not deduplicated)
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
511 | $87 | $254 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
118 | $124 | $364 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
92 | $61 | $146 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
48 | $112 | $500 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
20 | $131 | $368 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
20 | $159 | $448 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$15,300
Total received (2018-2024)
Avg $2,186/year across 7 years
Top 20% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
74
Companies
719
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,197
2023
$2,441
2022
$2,073
2021
$2,106
2020
$1,555
2019
$2,002
2018
$1,925
Payments by company (2024)
MITSUBISHI TANABE PHARMA AMERICA, INC.
$376
Lundbeck LLC
$322
Neurelis, Inc.
$263
Biogen, Inc.
$243
UCB, Inc.
$232
Takeda Pharmaceuticals U.S.A., Inc.
$222
SK Life Science, Inc.
$154
Novartis Pharmaceuticals Corporation
$153
ACADIA Pharmaceuticals Inc
$142
ARGENX US, INC.
$140
Otsuka America Pharmaceutical, Inc.
$138
Celgene Corporation
$88
TG Therapeutics, Inc.
$80
Lilly USA, LLC
$72
Amneal Pharmaceuticals LLC
$63
ABBVIE INC.
$58
LivaNova USA, Inc.
$58
Vanda Pharmaceuticals Inc.
$50
PFIZER INC.
$46
Alexion Pharmaceuticals, Inc.
$42
Genentech USA, Inc.
$31
Cycle Pharmaceuticals Inc
$28
Marinus Pharmaceuticals, Inc.
$27
Kyowa Kirin, Inc.
$27
Mallinckrodt Hospital Products Inc.
$25
Merz Pharmaceuticals, LLC
$25
Eisai Inc.
$21
SCILEX PHARMACEUTICALS INC.
$20
Teva Pharmaceuticals USA, Inc.
$18
CATALYST PHARMACEUTICALS, INC.
$17
MDD US Operations, LLC
$15
Top 3 companies account for 30.1% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$1,536
UCB, Inc.
$1,082
Teva Pharmaceuticals USA, Inc.
$874
Amgen Inc.
$824
GENZYME CORPORATION
$780
ACADIA Pharmaceuticals Inc
$614
LivaNova USA, Inc.
$595
Novartis Pharmaceuticals Corporation
$527
Lundbeck LLC
$487
SK Life Science, Inc.
$485
MITSUBISHI TANABE PHARMA AMERICA, INC.
$483
Neurelis, Inc.
$443
Genentech USA, Inc.
$430
Alexion Pharmaceuticals, Inc.
$423
Celgene Corporation
$391
PFIZER INC.
$385
Lilly USA, LLC
$345
Eisai Inc.
$337
Janssen Pharmaceuticals, Inc
$314
Sunovion Pharmaceuticals Inc.
$295
Takeda Pharmaceuticals U.S.A., Inc.
$271
ARGENX US, INC.
$212
ABBVIE INC.
$201
AbbVie Inc.
$190
Amneal Pharmaceuticals LLC
$186
Otsuka America Pharmaceutical, Inc.
$186
Supernus Pharmaceuticals, Inc.
$176
EMD Serono, Inc.
$142
Medtronic USA, Inc.
$133
Biohaven Pharmaceuticals, Inc.
$124
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$97
CSL Behring
$90
Corium, LLC
$88
BANNER LIFE SCIENCES, LLC
$86
TG Therapeutics, Inc.
$80
Jazz Pharmaceuticals Inc.
$73
Avanir Pharmaceuticals, Inc.
$63
US WorldMeds, LLC
$61
E.R. Squibb & Sons, L.L.C.
$59
Kyowa Kirin, Inc.
$53
Boston Scientific Corporation
$53
Biohaven Pharmaceutical Holding Company Ltd.
$52
Mallinckrodt Hospital Products Inc.
$50
Vanda Pharmaceuticals Inc.
$50
Adamas Pharmaceuticals, Inc.
$49
Aprecia Pharmaceuticals, LLC
$47
Neurocrine Biosciences, Inc.
$47
AbbVie, Inc.
$45
JAZZ PHARMACEUTICALS INC.
$44
Acorda Therapeutics, Inc
$42
Vertical Pharmaceuticals, LLC
$41
CATALYST PHARMACEUTICALS, INC.
$41
Avion Pharmaceuticals
$37
Impax Laboratories, Inc.
$36
Allergan, Inc.
$35
Cycle Pharmaceuticals Inc
$28
Greenwich Biosciences, Inc.
$28
Marinus Pharmaceuticals, Inc.
$27
MDD US Operations, LLC
$27
Merz Pharmaceuticals, LLC
$25
Mallinckrodt LLC
$25
AstraZeneca Pharmaceuticals LP
$23
Horizon Therapeutics plc
$23
EISAI INC.
$23
Akcea Therapeutics, Inc.
$20
SCILEX PHARMACEUTICALS INC.
$20
Strongbridge US INC.
$19
Bayer HealthCare Pharmaceuticals Inc.
$18
Scilex Pharmaceuticals Inc.
$18
Ultragenyx Pharmaceutical Inc.
$17
BOSTON SCIENTIFIC CORPORATION
$17
Currax Pharmaceuticals LLC
$16
Grifols USA, LLC
$15
ASSERTIO THERAPEUTICS, Inc.
$14
Top 3 companies account for 22.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Activase · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BRIUMVI · Briviact · CONTRAVE · CREXONT · Cambia · DAYBUE · DUOPA · Dhivy · Duopa · ELIQUIS · EMGALITY · EPIDIOLEX · EVUSHELD · Epidiolex · FIRDAPSE · FYCOMPA · Fycompa · GAMMAGARD · GENERAL DBS · GENERAL - DBS · GOCOVRI · Gamunex-C · General - DBS · Gocovri · HYQVIA · Hizentra · INBRIJA · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · OSMOLEX ER · Ocrevus · Ongentys · PANZYGA · PONVORY · Ponvory · QULIPTA · RADICAVA · REXULTI · RYTARY · Rebif · SOLIRIS · Spritam · Stivarga · TECFIDERA · TEGSEDI · TROKENDI XR · TYSABRI · Tascenso ODT · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · XARELTO · XIFAXAN · Xadago · Xeomin · ZAVZPRET · ZEPOSIA · ZTALMY · ZTLido · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
37
County median income
$63,644
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH HEART OF FLORIDA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Riaz is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Riaz experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Riaz performed 511 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Riaz receive payments from pharmaceutical companies?
Yes. Dr. Riaz received a total of $15,300 from 74 companies across 719 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Riaz's costs compare to other neurologists in Davenport?
Dr. Riaz's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Riaz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Davenport
Browse neurologists in Davenport ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology